Metin Kurtoglu

Company: Cartesian Therapeutics

Job title: Chief Medical Officer, Chief Good Manufacturing Practices & Technology Officer

Seminars:

Panel Discussion: Evaluating Safety & CMC Expectations between Different Cell Therapy Types & Autoimmune Indications

Moderator – Fred Aslan, Chief Executive Officer, Artiva Biotherapeutics 8:30 am

• Discussing the advantages and disadvantages of different cell therapy modalities when meeting CMC expectations • Understanding safety parameters that need to be demonstrated and how those may differ in various autoimmune indications • What are some of the standards that are set or need to be set for cell therapies to advance in the…Read more

day: Day Two AM